Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials

Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada. 2023-12-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCanada’s regulatory approachdrugs for rare-diseasesapply and register for clinical trials Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trialsHTML https://www.canada.ca/en/health-canada/services/licences-authorizations-registrations-drug-health-products/regulatory-approach-drugs-rare-diseases/clinical-trials-apply.html Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trialsHTML https://www.canada.ca/fr/sante-canada/services/licences-autorisation-et-enregistrement-medicaments-et-produits-sante/approche-canada-reglementation-medicaments-maladies-rares/essais-cliniques-demande.html

Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.

Data and Resources

Similar records